Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anne F. Pihl"'
Autor:
Jannick Prentoe, Christoph M Janitzek, Rodrigo Velázquez-Moctezuma, Louise Goksøyr, Rebecca W Olsen, Margherita Fanalista, Elias H Augestad, Susan Thrane, Anne F Pihl, Judith M Gottwein, Adam F Sander, Jens Bukh
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255336 (2021)
Yearly, about 1.5 million people become chronically infected with hepatitis C virus (HCV) and for the 71 million with chronic HCV infection about 400,000 die from related morbidities, including liver cirrhosis and cancer. Effective treatments exist,
Externí odkaz:
https://doaj.org/article/66c39541f9e1496cbb7f3e0e0d294e1a
Autor:
Garazi P. Alzua, Anne F. Pihl, Anna Offersgaard, Rodrigo Velázquez‐Moctezuma, Carlos R. Duarte Hernandez, Elias H. Augestad, Ulrik Fahnøe, Christian K. Mathiesen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jens Bukh, Judith M. Gottwein
Publikováno v:
Alzua, G P, Pihl, A F, Offersgaard, A, Velázquez-Moctezuma, R, Duarte Hernandez, C R, Augestad, E H, Fahnøe, U, Mathiesen, C K, Krarup, H, Law, M, Prentoe, J, Bukh, J & Gottwein, J M 2023, ' Identification of novel neutralizing determinants for protection against HCV ', Hepatology, vol. 73, no. 3, pp. 982-996 . https://doi.org/10.1002/hep.32772
Alzua, G P, Pihl, A F, Offersgaard, A, Velázquez-Moctezuma, R, Hernandez, C R D, Augestad, E H, Fahnøe, U, Mathiesen, C K, Krarup, H, Law, M, Prentoe, J, Bukh, J & Gottwein, J M 2023, ' Identification of novel neutralizing determinants for protection against HCV ', Hepatology, vol. 77, no. 3, pp. 982-996 . https://doi.org/10.1002/hep.32772
Alzua, G P, Pihl, A F, Offersgaard, A, Velázquez-Moctezuma, R, Hernandez, C R D, Augestad, E H, Fahnøe, U, Mathiesen, C K, Krarup, H, Law, M, Prentoe, J, Bukh, J & Gottwein, J M 2023, ' Identification of novel neutralizing determinants for protection against HCV ', Hepatology, vol. 77, no. 3, pp. 982-996 . https://doi.org/10.1002/hep.32772
BACKGROUND AND AIMS: HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine. N-linked glycosylation of viral envelope proteins is a key mechanism for such evasio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee8ddda5099418631770b24f323c860
https://curis.ku.dk/portal/da/publications/identification-of-novel-neutralizing-determinants-for-protection-against-hcv(8ae9404e-763e-4513-aa0e-d6bc1800cc97).html
https://curis.ku.dk/portal/da/publications/identification-of-novel-neutralizing-determinants-for-protection-against-hcv(8ae9404e-763e-4513-aa0e-d6bc1800cc97).html
Autor:
Keven, Lothert, Anna F, Offersgaard, Anne F, Pihl, Christian K, Mathiesen, Tanja B, Jensen, Garazi Peña, Alzua, Ulrik, Fahnøe, Jens, Bukh, Judith M, Gottwein, Michael W, Wolff
Publikováno v:
Scientific reports. 10(1)
There is a large unmet need for a prophylactic hepatitis C virus (HCV) vaccine to control the ongoing epidemic with this deadly pathogen. Many antiviral vaccines employ whole viruses as antigens. For HCV, this approach became feasible following the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96ad9cc22fe20e8f339f7f781b1f7803
https://pubmed.ncbi.nlm.nih.gov/33004836
https://pubmed.ncbi.nlm.nih.gov/33004836